News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
198 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (3339)
February (3294)
March (4068)
April (3458)
May (4782)
June (3455)
July (2690)
August (3589)
September (3334)
October (3977)
November (4082)
December (2500)
Day
1 (294)
2 (128)
3 (30)
4 (20)
5 (264)
6 (194)
7 (150)
8 (159)
9 (95)
10 (10)
11 (8)
12 (137)
13 (166)
14 (123)
15 (170)
16 (72)
17 (10)
18 (2)
19 (50)
20 (198)
21 (150)
22 (154)
23 (90)
24 (16)
25 (13)
26 (171)
27 (177)
28 (163)
29 (150)
30 (91)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Chinese Medical Journal Pulmonary and Critical Care Medicine Review Highlights Tumor Microenvironment-Targeted Cancer Immunotherapy
Non-small cell lung cancer is one of the most common and aggressive forms of cancer. Researchers have been exploring effective treatments to improve the survival rates of patients with NSCLC, such as by targeting the immune cells in the tumor microenvironment.
June 20, 2023
·
2 min read
Biotech Bay
Jaguar Health Subsidiary Becomes Corporate Partner of Multinational Association of Supportive Care in Cancer (MASCC)
Jaguar Health, Inc. (Nasdaq:JAGX) today announced that Napo Pharmaceuticals, Jaguar’s wholly owned subsidiary, is now a Corporate Partner of the Multinational Association of Supportive Care in Cancer (MASCC).
June 20, 2023
·
6 min read
Business
Curia Expands Cell Line Development Offering with CHOZN PlatformCuria signs license agreement with MilliporeSigma to support production of proteins and antibodies
Curia today announced it has signed a licensing agreement with MilliporeSigma, the North American Life Sciences Business of Merck KGaA, Darmstadt, Germany, that enables Curia and its clients to use the CHOZN® GS-/- cell line for production of therapeutic proteins and antibodies.
June 20, 2023
·
2 min read
Defence’s Proprietary Accum(TM) Technology for Delivery of CRISPR/Cas Genome-Editing Complexes Patent Application Published
Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (“Defence” or the “Company”), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies,
June 20, 2023
·
4 min read
Business
Nexcella Appoints Jeffrey H. Cooper, former Chief Financial Officer of BioMarin, to Board of Directors
Nexcella, Inc., announced that effective , Jeffrey H. Cooper, former Chief Financial Officer of BioMarin Pharmaceutical Inc., has been appointed to the Company’s Board of Directors.
June 20, 2023
·
5 min read
Business
Spinal Elements Announces Appointment of Susan Denman to the Board
Spinal Elements, a spine technology company, announced the appointment of Susan Denman to the Company’s Board of Directors.
June 20, 2023
·
3 min read
Biotech Beach
Aardvark Therapeutics Announces FDA Orphan Drug Designation Granted to ARD-101, a Novel Drug Candidate for Prader-Willi Syndrome
Aardvark Therapeutics, Inc., a clinical stage biopharmaceutical company, today reported receipt of an Orphan Drug Designation from the FDA for its lead program, ARD-101, an oral small molecule bitter taste receptor (TAS2R) agonist.
June 20, 2023
·
4 min read
Mindpeak And Proscia Partner To Improve Cancer Diagnosis With Integrated AI-Powered Pathology Workflows
Collaboration marks step forward in realizing the promise of precision medicine
June 20, 2023
·
4 min read
BioMidwest
Visura Technologies Presents TEECAD Real-World Clinical Data at ASE 2023
Visura Technologies, Inc. announced it will be attending the American Society of Echocardiography’s 34th Annual Scientific Sessions in Baltimore, MD June 23-26.
June 20, 2023
·
3 min read
Business
Orthofix Announces Changes to Board of Directors - June 20, 2023
Orthofix Medical Inc., a leading global spine and orthopedics company, announced that Catherine Burzik has been re-appointed as the Chair of the Company’s Board of Directors.
June 20, 2023
·
3 min read
Previous
19 of 20
Next